Management of central nervous system metastases in breast cancer

Ricardo Costa*, Priya U Kumthekar

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

The cumulative incidence of brain metastasis at 5 years is approximately 5% in patients with breast cancer but is much higher in postmortem autopsy series. Overall breast cancer is the second most common cause of brain metastasis. Leptomeningeal metastatic disease is rarer at less than 1%. Metastatic epidural spinal cord compression preceding death due to breast cancer has been reported at 5.52%. Prompt diagnosis and treatment before the development of paralysis or paresis is associated with a better prognosis. Patients who present with cord compression without paresis can be adequately treated with radiation therapy (RT) alone (with or without corticosteroids). Patients who present with paresis or paralysis are less likely to regain neurologic function and have a worse prognosis. These patients require urgent evaluation and may be best treated with immediate decompression through surgery followed by postoperative RT.

Original languageEnglish (US)
Title of host publicationThe Breast
Subtitle of host publicationComprehensive Management of Benign and Malignant Diseases
PublisherElsevier Inc
Pages942-960.e7
ISBN (Print)9780323359559
DOIs
StatePublished - Jan 1 2018

Keywords

  • Brain metastases
  • Central nervous system metastases
  • Metastatic breast cancer

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Management of central nervous system metastases in breast cancer'. Together they form a unique fingerprint.

Cite this